Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of low molecular weight heparin in regulating uterine immune microenvironment and IVF outcomes
ChiCTR2000040464Phase 4Recruiting
- Sponsor
- Ruijin Hospital
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of low molecular weight heparin calcium in female infertility, sponsored by Ruijin Hospital. Primary endpoint: Cytokine profiles of uterine fluid. Started Dec 2020; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR2000040464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040464.